Close Menu

Prosolia

Waters said the acquisition is part of a strategy to develop simpler, more streamlined mass spec workflows that will be accessible to non-expert users.

As part of the deal, Waters has also placed a Synapt G2-Si mass spec instrument at Purdue University to help advance research applications for DESI.

The company registered its Prelude LX-4 MD HPLC as a Class I medical device for general clinical use. 

While LC-MS/MS workflows using triple quadrupoles and, more recently, Q-TOF and Q-Exactive instruments, have typically dominated discussion of mass spec-based protein quantitation, MALDI mass spec has recently emerged as a potential alternative for such applications.

NEW YORK (GenomeWeb News) – AB Sciex has licensed to Prosolia a portfolio of new sample introduction and ionization methods based on a liquid microjunction surface sampling approach.

The company will use GSG Mess-und Analysnegerate for marketing and distribution in Germany, Austria, and Switzerland.

Movers & Shakers: Oct 15, 2010

Premium

Justin Wiseman, Peter Kissinger, Kevin Boscacci, John Hertig, Peter Lewis

Ivan Trifunovich is now CEO at Helicos, NIH staff is elected to IOM, Richard Scott Tobin has stepped down from all positions at Health Discovery Corp., and more

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.